TRAWS PHARMA INC (TRAW)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$0.55+1.49%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · TRAW
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||
| Revenues | — | 2.8 | 2.8 | 0.2 | 0.2 | 0.2 | 0.2 | 2.2 | 1.2 | 0.8 | 5.5 | 11.5 | 0.8 | 4.8 |
| Total Revenues | — | 2.8 | 2.8 | 0.2 | 0.2 | 0.2 | 0.2 | 2.2 | 1.2 | 0.8 | 5.5 | 11.5 | 0.8 | 4.8 |
| Operating Expenses & Income | ||||||||||||||
| R&D Expenses | — | — | — | 11.4 | 11.4 | 7.3 | 16.9 | 15.5 | 16.9 | 19.1 | 20.1 | 25.9 | 49.4 | 50.2 |
| Operating Income | (21.5) | (17.9) | (17.9) | (20.3) | (19.6) | (16.5) | (25.0) | (21.7) | (23.3) | (25.7) | (23.7) | (24.0) | (63.7) | (62.2) |
| Earnings from Continuing Operations | ||||||||||||||
| Interest Expense | — | — | — | — | — | — | — | — | — | — | — | — | 0.0 | 0.0 |
| Interest & Investment Income | — | 0.5 | 0.5 | 1.4 | 0.7 | — | — | — | — | — | — | — | — | — |
| Asset Writedown | — | 0.0 | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| EBT, Incl. Unusual Items | — | 9.2 | 9.2 | (18.9) | (19.0) | (16.2) | (25.2) | (21.5) | (20.5) | (24.1) | (19.7) | (24.0) | (63.8) | (62.1) |
| Income Tax Expense | — | — | — | — | — | — | 0.0 | 0.0 | (0.1) | 0.0 | 0.0 | 0.0 | 0.0 | 0.4 |
| Net Income | ||||||||||||||
| Minority Interest | — | — | — | — | — | — | — | 0.2 | 0.2 | — | (0.0) | (0.0) | (0.1) | (0.0) |
| Net Income | (21.6) | 9.2 | 9.2 | (18.9) | (19.0) | (16.2) | (25.2) | (21.5) | (20.6) | (24.1) | (19.7) | (24.0) | (63.7) | (62.5) |
| Per Share | ||||||||||||||
| Basic EPS | (1.36) | 0.83 | 0.83 | (22.57) | (0.91) | (0.96) | (2.17) | — | — | — | — | — | — | — |
| Diluted EPS | (1.36) | 0.82 | 0.82 | (22.57) | (0.91) | (0.96) | (2.17) | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 15.9 | 8.2 | 8.2 | 0.8 | 20.9 | 16.8 | 11.6 | — | — | — | — | — | — | — |
| Diluted Weighted Avg Shares | 15.9 | 8.4 | 8.4 | 0.8 | 20.9 | 16.8 | 11.6 | — | — | — | — | — | — | — |
| Supplemental | ||||||||||||||
| EBITDA | — | (17.8) | (17.8) | (20.3) | (19.6) | (16.5) | (25.0) | (21.7) | (23.2) | (25.6) | (23.6) | (23.8) | (63.3) | (61.8) |
| EBIT | (21.5) | (17.9) | (17.9) | (20.3) | (19.6) | (16.5) | (25.0) | (21.7) | (23.3) | (25.7) | (23.7) | (24.0) | (63.7) | (62.2) |
| Effective Tax Rate | — | — | — | — | — | — | -0.0% | -0.0% | 0.6% | -0.1% | -0.1% | -0.1% | -0.0% | -0.7% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.